Socioeconomic status and quality of life in patients with locally advanced head and neck cancer; [Sozioökonomischer Status und Lebensqualität bei Patienten mit lokal fortgeschrittenen Kopf-Hals-Tumoren]

被引：0

作者：

Tribius S. ^{[1
]}

Meyer M.S. ^{[2
]}

Pflug C. ^{[3
]}

Hanken H. ^{[4
]}

Busch C.-J. ^{[5
]}

Krüll A. ^{[2
]}

Petersen C. ^{[2
]}

Bergelt C. ^{[6
]}

机构：

[1] Department of Radiation Oncology, Asklepios Hospital St. Georg, Lohmühlenstraße 5, Hamburg

[2] Department of Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg

[3] Department of Voice, Speech and Hearing Disorders, Center for Clinical Neurosciences, University Medical Center Hamburg-Eppendorf, Hamburg

[4] Department of Oral & Maxillofacial Surgery, Center for Clinical Neurosciences, University Medical Center Hamburg-Eppendorf, Hamburg

[5] Department of Otolaryngology, Center for Clinical Neurosciences, University Medical Center Hamburg-Eppendorf, Hamburg

[6] Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg

来源：

Strahlentherapie und Onkologie | 2018年 / 194卷 / 8期

关键词：

Head and neck cancer; Intensity-modulated radiotherapy; Quality of life; Rehabilitation; Socioeconomic status;

D O I：

10.1007/s00066-018-1305-3

中图分类号：

学科分类号：

摘要：

Purpose: Socioeconomic aspects play an important role in health care. Patients with locally advanced head and neck cancer (LAHNC) experience detrimental effects on their quality of life (QoL). This prospective study examines QoL differences between patients with different socioeconomic status (SES) after intensity-modulated radiation therapy (IMRT). Patients and methods: In all, 161 patients were questioned at the end of IMRT and at 12 and 24 months follow-up using the questionnaires of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-30 and QLQ-HN35. Patients’ QoL 2 years after IMRT was compared to a population reference sample and QoL of patients from lower, middle, and higher social class 2 years after IMRT was analyzed by ANCOVA using baseline QoL (end of radiation treatment) as a covariate. Results: Patients with high SES report worse QoL at the end of IMRT in the domains global health status (−15.2; p = 0.005), role function (−23.8; p = 0.002), and social function (−19.4; p = 0.023) compared to patients with middle and low SES. QoL improved during the first 12 and 24 months. However, 2 years after IMRT, middle and low SES patients report lower QoL in the domains global health status, physical function, and role function, and report a higher general (fatigue, pain, dyspnea) and head and neck cancer-specific symptom burden (pain, swallowing, senses, speech, social eating, opening mouth, and felt ill) than patients with high SES. Conclusion: After IMRT for LAHNC, patients with high SES report worse QoL compared to patients with middle or low SES. There is a marked improvement within the first 24 months in many domains. However, the magnitude of improvement in patients with middle or low SES is significantly smaller compared to patients with high SES. © 2018, Springer-Verlag GmbH Germany, part of Springer Nature.

引用

页码：737 / 749

页数：12

共 50 条

[1] Sequential and simultaneous radiochemotherapy in locally advanced head and neck tumors [Sequentielle und simultane radiochemotherapie bei lokal fortgeschrittenen Kopf-Hals-Tumoren]
Budach V.
Budach W.
Der Onkologe, 2001, 7 (5): : 533 - 549
[2] Long-term quality of life in head and neck cancer patientsA systematic reviewLangzeitlebensqualität bei Patienten mit Kopf-Hals-Tumoren
Katherine Taylor
Susanne Singer
Der Onkologe, 2019, 25 : 125 - 131
[3] Chemotherapie bei Patienten mit Kopf-Hals-Tumoren im AlterIndikationen und LimitationenChemotherapy in elderly patients with head and neck tumorsIndications and limitations
M. Koenigsmann
Der MKG-Chirurg, 2015, 8 (1): : 28 - 30
[4] Unilateral cochlea sparing in locoregionally advanced head and neck cancer: a planning studyEinseitige Schonung der Cochlea bei lokal fortgeschrittenen Kopf-Hals-Tumoren: eine Planungsstudie
L. H. Braun
K. Braun
B. Frey
S. M. Wolpert
H. Löwenheim
D. Zips
S. Welz
Strahlentherapie und Onkologie, 2018, 194 : 1124 - 1131
[5] Taxane-containing induction chemotherapy followed by definitive chemoradiotherapyOutcome in patients with locally advanced head and neck cancerTaxanhaltige Induktionschemotherapie gefolgt von definitiver RadiochemotherapieResultate von Patienten mit lokal fortgeschrittenen Kopf-Hals-Tumoren
J.O. Brömme
M. Schmücking
A. Arnold
R. Giger
D. Rauch
D. Leiser
L. Plasswilm
A. Geretschläger
P. Ghadjar
D.M. Aebersold
Strahlentherapie und Onkologie, 2013, 189 (8) : 618 - 624
[6] Was ist das Besondere bei der Palliativversorgung von Patienten mit Kopf-Hals-Tumoren?What is special in patients with head and neck cancer?
B. Alt-Epping
F. Nauck
Der MKG-Chirurg, 2021, 14 (1): : 29 - 34
[7] Lebensqualitätsmessungen bei Patienten mit Kopf-Hals-MalignomenAktueller Stand und zukünftige AnforderungenMeasuring quality of life in head and neck cancerCurrent status and future needs
A. Dietz
A. Meyer
S. Singer
HNO, 2009, 57 (9) : 857 - 865
[8] Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study [Residuale Defizite in der Lebensqualität ein Jahr nach intensitätsmodulierter Strahlentherapie bei Patienten mit lokal fortgeschrittenen Kopf-Hals-Tumoren: Ergebnisse einer prospektiven Studie]
Tribius S.
Raguse M.
Voigt C.
Münscher A.
Gröbe A.
Petersen C.
Krüll A.
Bergelt C.
Singer S.
Strahlentherapie und Onkologie, 2015, 191 (6) : 501 - 510
[9] „Neck Dissection“ bei residuellen Lymphknotenbefunden von lokal fortgeschrittenen Kopf-Hals-Tumoren nach primärer StrahlenchemotherapieNeck dissection of the residually positive neck after primary radiochemotherapy for locally advanced head and neck cancer
H. Christiansen
R.M.W. Rödel
Strahlentherapie und Onkologie, 2012, 188 (5) : 444 - 445
[10] Simultane radiochemotherapie mit carboplatin bei patienten mit inoperablen fortgeschrittenen Kopf-Hals-Tumoren der stadien UICCIII und IVConcurrent radiotherapy and chemotherapy with carboplatin in patients with unresectable advanced head and neck tumors stages III and IV
Ralph Mücke
Martina Blynow
Peter-Georg Ziegler
Torsten Libera
Günther Kundt
Steffen Dommerich
Burkhard Kramp
Rainer Fietkau
Strahlentherapie und Onkologie, 1999, 175 (5) : 213 - 217

← 1 2 3 4 5 →